The phase 3 trial of the RTS,S/AS01 malaria vaccine candidate showed modest efficacy of the vaccine against Plasmodium falciparum malaria, but was not powered to assess mortality endpoints. Impact projections and cost-effectiveness estimates for longer timeframes than the trial follow-up and across a range of settings are needed to inform policy recommendations. We aimed to assess the public health impact and cost-effectiveness of routine use of the RTS,S/AS01 vaccine in African settings.
Original Source [2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/public-health-impact-and-cost-effectiveness-rtssas01-malaria-vaccine-systematic
[2] http://www.lancet.com/journals/lancet/article/PIIS0140-6736(15)00725-4/abstract
[3] http://admin.indiaenvironmentportal.org.in/category/author/melissa-penny
[4] http://admin.indiaenvironmentportal.org.in/category/author/robert-verity
[5] http://admin.indiaenvironmentportal.org.in/category/author/caitlin-bever-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/lancet
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/public-sector
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/private-sector
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-borne-diseases
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
[15] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
